SEER Inquiry System - Search

Reportability/Histology--Heme & Lymphoid Neoplasms: Is a diagnosis of myeloid stem cell disorder or myeloid stem cell neoplasm reportable when the differential diagnosis includes only reportable neoplasms? If so, how should histology be coded? See Discussion.

Reportability/Histology--Kidney: Is an oncocytic renal neoplasm of low malignant potential (ORNLMP) reportable? See Discussion.

Reportability/Histology--Kidney: Is hybrid oncocytic chromophobe tumor reportable for cases diagnosed 2021 and later? If so, how is the histology coded? See Discussion.

Reportability/Histology--Kidney:  What is the histology and behavior of a papillary renal neoplasm with reverse polarity? See Discussion.

Reportability/Histology--Liver: Are primary hepatic neuroendocrine neoplasm and primary hepatic neuroendocrine tumor (PHNET) reportable? What are the specific histology codes?

Reportability/Histology--Lung: Are adenocarcinoma spectrum lesions on lung imaging reportable when no further information is available? See Discussion.

Reportability/Histology--Ovary/Testis: Is serous borderline tumor-micropapillary variant (8460/2) of the ovary or testis reportable? If so, what dates are applicable to the reportability changes?  See Discussion.

Reportability/Histology--Ovary: Is a 2020 ovary case reportable with the positive malignant findings in adnexal cystic fluid and peritoneal washing? See Discussion.

Reportability/Histology--Pancreas: Is a diagnosis of insulin-producing (insulinoma) epithelioid neoplasm reportable if made 2021 and later? If so, is the histology coded as 8151/3 per the ICD-O-3.2 Coding Table? See Discussion.

Reportability/Histology--Pancreas: Is mucinous cystic neoplasm of pancreas reportable?